Bloom Energy: A Fleeting Iridescence

by

Bloom Energy (BE +7.40%)—a name that, to the uninitiated, suggests a horticultural enterprise rather than a purveyor of electrochemical solutions—experienced a momentary efflorescence this Tuesday, ascending some 8% by mid-morning. A curious bloom, indeed, and one largely attributable, it seems, to the pronouncements of Roth Capital.

The Analyst’s Affection

This morning, Roth Capital, with a flourish worthy of a baroque composer, revised its price target for Bloom stock upwards—to $133 per share, a 29% augmentation. A rather bold stroke, considering the underlying substrate. The market, ever susceptible to such pronouncements, reacted with predictable alacrity. One wonders if the analysts themselves truly believe in this particular alchemy, or if it is merely a performance—a dazzling display of financial ventriloquism.

The impending Q4 earnings report—scheduled for release after the close of trading on February 5th—casts a somewhat pallid light upon this exuberance. Forecasts suggest a decline in earnings per share—from $0.43 to a mere $0.30—and these figures, it should be noted, are likely “adjusted,” a term that often serves as a euphemism for artful accounting. Still, Roth Capital appears undeterred, anticipating, with a confidence bordering on the preternatural, forthcoming order announcements and optimistic guidance. Precisely what form this guidance will take remains shrouded in a delightful ambiguity.

Loading widget...

A Speculative Garden?

Now, let us not succumb to excessive enthusiasm. Bloom stock, having already ascended to heights that would make Icarus blush—a 575% increase over the past year—appears, shall we say, richly valued. Even Roth Capital acknowledges this, cautioning that forward expectations are already factoring in a rather substantial influx of orders and capacity growth. A curious admission, hinting that the potential for further gains may be…limited. The stock, in essence, has already inhaled a considerable amount of oxygen.

Consequently, Roth Capital maintains a “neutral” rating—a tepid endorsement, to be sure. I, however, view the situation with a more discerning eye. With Bloom stock trading at a multiple of approximately 2,000 times trailing earnings—and over 180 times next year’s earnings, even assuming it achieves its ambitious targets—I find myself leaning towards a decidedly bearish perspective. It’s a beautiful, fragile bloom, certainly, but one that seems destined to wither under the weight of its own expectations. A speculative garden, perhaps, but one where the weeds threaten to overtake the flowers.

Read More

2026-02-03 19:52